
CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …
PCTs have received a mixed report from practice-based commissioners, less than a third of who rate the quality of PCT …
Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …

